openPR Logo
Press release

Lawsuit filed for Investors in shares of Gossamer Bio, Inc. (NASDAQ: GOSS)

04-15-2020 07:13 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Gossamer Bio, Inc. (NASDAQ: GOSS) shares over alleged securities laws violations.

A lawsuit was filed on behalf of investors in Gossamer Bio, Inc. (NASDAQ: GOSS) shares over alleged securities laws violations.

An investor, who purchased shares of Gossamer Bio, Inc. (NASDAQ: GOSS), filed a lawsuit over alleged violations of Federal Securities Laws by Gossamer Bio, Inc..

Investors who purchased shares of Gossamer Bio, Inc. (NASDAQ: GOSS) have certain options and for certain investors are short and strict deadlines running. Deadline: June 2, 2020. NASDAQ: GOSS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Gossamer Bio, Inc's most advanced product is its GB001 drug, a DP2 antagonist, in development to treat asthma. In February 2019, Gossamer Bio, Inc conducted its initial public offering ("IPO"), issuing approximately 19.8 million shares of common stock priced at $19.00 per share.

Then, on December 16, 2019, Novartis announced that it was terminating the development of its DP2 antagonist for asthma after it failed a pair of phase 3 clinical trials.

The plaintiff claims that the materials supporting Gossamer's IPO, and certain of Gossamer's post-IPO public filings, misled investors or otherwise omitted material facts relevant to Gossamer's GB001 drug and its related clinical trials and studies. The plaintiff alleges that the Defendants misrepresented and/or failed to disclose to investors: (1) the reasons for Gossamer's GB001 trial failures; (2) the purported clinical validation of Novartis'oral DP2 antagonist; and (3) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.

Those who purchased shares of Gossamer Bio, Inc. (NASDAQ: GOSS) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in shares of Gossamer Bio, Inc. (NASDAQ: GOSS) here

News-ID: 2012289 • Views:

More Releases from Shareholders Foundation

Investors in Thoughtworks Holding, Inc. (NASDAQ: TWKS) should contact the Shareholders Foundation in connection with Taekover by Apax funds
Investors in Thoughtworks Holding, Inc. (NASDAQ: TWKS) should contact the Shareh …
An investigation was announced concerning whether the takeover of Thoughtworks Holding, Inc. is unfair to NASDAQ: TWKS stockholders. Investors who purchased shares of Thoughtworks Holding, Inc. (NASDAQ: TWKS) and currently hold any of those NASDAQ: TWKS shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Thoughtworks Holding, Inc. breached their
Investigation announced for Investors who lost money with shares of Domino's Pizza, Inc. (NYSE: DPZ) Investor over possible Violations of Securities Laws
Investigation announced for Investors who lost money with shares of Domino's Piz …
An investigation was announced for investors of Domino's Pizza, Inc. (NYSE: DPZ) shares over potential securities laws violations by Domino's Pizza, Inc. Investors who purchased shares of Domino's Pizza, Inc. (NYSE: DPZ), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Domino's Pizza, Inc. (NYSE: DPZ)
Investigation announced for Long-Term Investors in shares of Ocugen, Inc. (NASDAQ: OCGN)
Investigation announced for Long-Term Investors in shares of Ocugen, Inc. (NASDA …
An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of Ocugen, Inc. Investors who are current long term investors in Ocugen, Inc. (NASDAQ: OCGN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: OCGN stocks follows a lawsuit filed against Ocugen, Inc. over alleged
Investigation announced for Investors who lost money with shares of Dayforce Inc (NYSE: DAY)
Investigation announced for Investors who lost money with shares of Dayforce Inc …
An investigation was announced for investors of Dayforce Inc (NYSE: DAY) shares over potential securities laws violations by Dayforce Inc. Investors who purchased shares of Dayforce Inc (NYSE: DAY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Dayforce Inc regarding its business, its prospects and its operations were materially

All 5 Releases


More Releases for Gossamer

Biomimetic Aircraft Market Foreseen to Grow Exponentially by 2028 - Top Companie …
Biomimetic Aircraft Market report by "The Insight Partners" sheds light on the key drivers and opportunities attributing to market expansion over the analysis period. It also gives in-depth information pertaining to the challenges and threats poised to hinder revenue generation in the forthcoming years. Additionally, the report also provides crucial information regarding leading companies in this business sphere and the trends that are likely to prevail in the near future.
Investigation announced for Long-Term Investors in shares of Gossamer Bio, Inc. …
An investigation was announced for current long-term investors in shares of Gossamer Bio, Inc. (NASDAQ: GOSS) concerning potential breaches of fiduciary duties by certain directors of Gossamer Bio, Inc. Investors who are current long term investors in Gossamer Bio, Inc. (NASDAQ: GOSS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors
Deadline upcoming on June 2nd in Lawsuit for Investors in shares of Gossamer Bio …
The Shareholders Foundation announced that a deadline is coming up on June 2, 2020 in the lawsuit filed for certain investors of Gossamer Bio, Inc. (NASDAQ: GOSS) over alleged securities laws violations by Gossamer Bio, Inc. Investors who purchased shares of Gossamer Bio, Inc. (NASDAQ: GOSS) have certain options and there are strict and short deadlines running. Deadline: June 2, 2020. NASDAQ: GOSS stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Investigation announced for Investors in shares of Gossamer Bio, Inc. (NASDAQ: G …
An investigation was announced concerning possible violations of securities laws by Gossamer Bio, Inc. in connection with certain financial statements. Investors who purchased shares of Gossamer Bio, Inc. (NASDAQ: GOSS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Gossamer Bio, Inc. regarding its business, its prospects and its operations
Global Outdoor Adventure Mats Market Forecasts and Opportunities 2019: Key Playe …
The global Outdoor Adventure Mats market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Outdoor Adventure Mats volume and value at global level, regional level and company level. From a global perspective, this report represents overall Outdoor Adventure Mats market size by analyzing historical data and future prospect. Request Sample
Outdoor Adventure Mats Market Size, Share, Growth, Trend, Industry Analysis and …
Outdoor Adventure Mats Industry 2018 Global research report is a professional and in-depth study on the market size, growth, share, trends as well as industry analysis. The information presented in this report provides an overview of the latest trends and development plans, patterns, and policies observed in the global market. Moreover, the study provides an analysis of the latest events such as the technological advancements and the product launches and